Immunohistochemical characterisation and localisation of cannabinoid CB1 receptor protein in the rat vestibular nucleus complex and the effects of unilateral vestibular deafferentation

被引:24
|
作者
Ashton, JC [1 ]
Zheng, YW [1 ]
Liu, P [1 ]
Darlington, CL [1 ]
Smith, PF [1 ]
机构
[1] Univ Otago, Sch Med, Dept Pharmacol & Toxicol, Sch Med Sci, Dunedin, New Zealand
关键词
CB1; receptor; unilateral vestibular deafferentation; vestibular nucleus complex;
D O I
10.1016/j.brainres.2004.06.065
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
CB1 receptor expression has been reported to be low in the brainstem compared with the forebrain, and low in the vestibular nucleus complex (VNC) compared with other regions in the brainstem. However, a frequent effect of cannabis is dizziness and loss of balance. This may be due to the activation of cannabinoid receptors in the central vestibular pathways. We used immunohistochemistry to study the distribution of CB1 receptor protein in the VNC, and Western blotting to measure CB 1 receptor expression in the VNC following unilateral vestibular deafferentation (UVD); the hippocampal CA1, CA2/3 and dentate gyrus (DG) regions were also analysed for comparison. This study confirms a previous electrophysiological demonstration that CB1 receptors exist in significant densities in the VNC and are likely to contribute to the neurochemical control of the vestibular reflexes. Nonetheless, CB1 receptor expression did not change significantly in the VNC during vestibular compensation. In addition, despite some small but significant changes in CB1 receptor expression in the CA2/3 and the DG following UVD, in no case were these differences statistically significant in comparison to both control groups. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:264 / 271
页数:8
相关论文
共 43 条
  • [41] Effects on turning of microinjections into basal ganglia of D1 and D2 dopamine receptors agonists and the cannabinoid CB1 antagonist SR141716A in a rat Parkinson's model
    El Banoua, F
    Caraballo, I
    Flores, JA
    Galan-Rodriguez, B
    Fernandez-Espejo, E
    NEUROBIOLOGY OF DISEASE, 2004, 16 (02) : 377 - 385
  • [42] Effects of the peripheral CB1 receptor antagonist JD5037 in mono- and polytherapy with the AMPK activator metformin in a monocrotaline-induced rat model of pulmonary hypertension
    Remiszewski, Patryk
    Pedzinska-Betiuk, Anna
    Minczuk, Krzysztof
    Schlicker, Eberhard
    Klimek, Justyna
    Dzieciol, Janusz
    Malinowska, Barbara
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [43] Modulatory role of the intra-accumbal CB1 receptor in protein level of the c-fos and pCREB/CREB ratio in the nucleus accumbens and ventral tegmental area in extinction and morphine seeking in the rats
    Khaleghzadeh-Ahangar, Hossein
    Khodagholi, Fariba
    Shaerzadeh, Fatemeh
    Haghparast, Abbas
    BRAIN RESEARCH BULLETIN, 2018, 142 : 320 - 327